The use of transpulmonary contrast echocardiography: A first experience in Serbia

Background/Aim. Contrast echocardiography (CE) is an echocardiographic modality where ultrasound contrast echocardiographic agent (CEA) is introduced peripherally for the image enhancement. The aim of this study was to present the initial clinical experience of the use of CEA Optison™ (GE Healthcare...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Stojšić-Milosavljević Anastrazija, Ilić Aleksandra, Stojšić Snežana, Ivanović Vladimir, Milićević Jelena, Kovač Robert, Stefanović Maja, Tadić Snežana, Miljković Tatjana, Bjelobrk Marija, Dabović Dragana, Živkov-Šaponja Dragoslava, Petrović Milovan, Aleksandar Redžek
Formato:	article
Lenguaje:	EN SR
Publicado:	Military Health Department, Ministry of Defance, Serbia 2021
Materias:	adverse drug reaction reporting systems cardiovascular diseases comorbidity contrast media echocardiography Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/8cc6d75e21a24e79b95294a74de989d0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8cc6d75e21a24e79b95294a74de989d0
record_format	dspace
spelling	oai:doaj.org-article:8cc6d75e21a24e79b95294a74de989d02021-11-10T07:27:57ZThe use of transpulmonary contrast echocardiography: A first experience in Serbia0042-84502406-072010.2298/VSP190127020Shttps://doaj.org/article/8cc6d75e21a24e79b95294a74de989d02021-01-01T00:00:00Zhttp://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84502000020S.pdfhttps://doaj.org/toc/0042-8450https://doaj.org/toc/2406-0720Background/Aim. Contrast echocardiography (CE) is an echocardiographic modality where ultrasound contrast echocardiographic agent (CEA) is introduced peripherally for the image enhancement. The aim of this study was to present the initial clinical experience of the use of CEA Optison™ (GE Healthcare, Princeton, NJ) at the Institute for Cardiovascular Diseases of Vojvodina, Serbia and prospectively monitor the occurrence of possible side effects. Methods. A total of 357 patients were referred for resting or stress echocardiographic examinations, with an approved indication for CEA administration. The average age of patients was 63.3 years (range, 21–92 years), 62% of them were men. Most of the patients (77.31%) had some form of ischemic heart diseases. Hypertension was the most frequent risk factor (77.03%), but 57 patients had diabetes mellitus and 33 patients had chronic kidney disease as comorbidity. Most (90.5%) of the patients were on beta blocker therapy, 83.5% of them on angiotensin converting enzyme/angiotensin receptor blockers. Majority (80.3%) of the patients received single or dual (49.5%) antiagregation therapy, 74 (26.3%), of them were on anticoagulation therapy, 55.1% of the patients were taking diuretics. The global ejection fraction (EF) was preserved in 39.85% of them, the majority (136 of them), had left ventricle (LV) impairment, with an EF less than 50%. Patients were followed up for 30 minutes after CEA administration for potential side effects. In 118 patients, vital signs (heart rate, oxygen saturation, body temperature, systolic and diastolic blood pressure) were measured before and 30 minutes after CEA administration. Results. The administration of CEA was not associated with side effects. Diastolic blood pressure drop and heart rate increase were statistically, but not clinically significant (p = 0.027 and p = 0.028, respectively). Conclusion. Changes in analyzed vital signs were clinically non relevant. CE is a safe noninvasive diagnostic modality for patients undergoing rest and stress echocardiography.Stojšić-Milosavljević AnastrazijaIlić AleksandraStojšić SnežanaIvanović VladimirMilićević JelenaKovač RobertStefanović MajaTadić SnežanaMiljković TatjanaBjelobrk MarijaDabović DraganaŽivkov-Šaponja DragoslavaPetrović MilovanAleksandar RedžekMilitary Health Department, Ministry of Defance, Serbiaarticleadverse drug reaction reporting systemscardiovascular diseasescomorbiditycontrast mediaechocardiographyMedicine (General)R5-920ENSRVojnosanitetski Pregled, Vol 78, Iss 10, Pp 1036-1045 (2021)
institution	DOAJ
collection	DOAJ
language	EN SR
topic	adverse drug reaction reporting systems cardiovascular diseases comorbidity contrast media echocardiography Medicine (General) R5-920
spellingShingle	adverse drug reaction reporting systems cardiovascular diseases comorbidity contrast media echocardiography Medicine (General) R5-920 Stojšić-Milosavljević Anastrazija Ilić Aleksandra Stojšić Snežana Ivanović Vladimir Milićević Jelena Kovač Robert Stefanović Maja Tadić Snežana Miljković Tatjana Bjelobrk Marija Dabović Dragana Živkov-Šaponja Dragoslava Petrović Milovan Aleksandar Redžek The use of transpulmonary contrast echocardiography: A first experience in Serbia
description	Background/Aim. Contrast echocardiography (CE) is an echocardiographic modality where ultrasound contrast echocardiographic agent (CEA) is introduced peripherally for the image enhancement. The aim of this study was to present the initial clinical experience of the use of CEA Optison™ (GE Healthcare, Princeton, NJ) at the Institute for Cardiovascular Diseases of Vojvodina, Serbia and prospectively monitor the occurrence of possible side effects. Methods. A total of 357 patients were referred for resting or stress echocardiographic examinations, with an approved indication for CEA administration. The average age of patients was 63.3 years (range, 21–92 years), 62% of them were men. Most of the patients (77.31%) had some form of ischemic heart diseases. Hypertension was the most frequent risk factor (77.03%), but 57 patients had diabetes mellitus and 33 patients had chronic kidney disease as comorbidity. Most (90.5%) of the patients were on beta blocker therapy, 83.5% of them on angiotensin converting enzyme/angiotensin receptor blockers. Majority (80.3%) of the patients received single or dual (49.5%) antiagregation therapy, 74 (26.3%), of them were on anticoagulation therapy, 55.1% of the patients were taking diuretics. The global ejection fraction (EF) was preserved in 39.85% of them, the majority (136 of them), had left ventricle (LV) impairment, with an EF less than 50%. Patients were followed up for 30 minutes after CEA administration for potential side effects. In 118 patients, vital signs (heart rate, oxygen saturation, body temperature, systolic and diastolic blood pressure) were measured before and 30 minutes after CEA administration. Results. The administration of CEA was not associated with side effects. Diastolic blood pressure drop and heart rate increase were statistically, but not clinically significant (p = 0.027 and p = 0.028, respectively). Conclusion. Changes in analyzed vital signs were clinically non relevant. CE is a safe noninvasive diagnostic modality for patients undergoing rest and stress echocardiography.
format	article
author	Stojšić-Milosavljević Anastrazija Ilić Aleksandra Stojšić Snežana Ivanović Vladimir Milićević Jelena Kovač Robert Stefanović Maja Tadić Snežana Miljković Tatjana Bjelobrk Marija Dabović Dragana Živkov-Šaponja Dragoslava Petrović Milovan Aleksandar Redžek
author_facet	Stojšić-Milosavljević Anastrazija Ilić Aleksandra Stojšić Snežana Ivanović Vladimir Milićević Jelena Kovač Robert Stefanović Maja Tadić Snežana Miljković Tatjana Bjelobrk Marija Dabović Dragana Živkov-Šaponja Dragoslava Petrović Milovan Aleksandar Redžek
author_sort	Stojšić-Milosavljević Anastrazija
title	The use of transpulmonary contrast echocardiography: A first experience in Serbia
title_short	The use of transpulmonary contrast echocardiography: A first experience in Serbia
title_full	The use of transpulmonary contrast echocardiography: A first experience in Serbia
title_fullStr	The use of transpulmonary contrast echocardiography: A first experience in Serbia
title_full_unstemmed	The use of transpulmonary contrast echocardiography: A first experience in Serbia
title_sort	use of transpulmonary contrast echocardiography: a first experience in serbia
publisher	Military Health Department, Ministry of Defance, Serbia
publishDate	2021
url	https://doaj.org/article/8cc6d75e21a24e79b95294a74de989d0
work_keys_str_mv	AT stojsicmilosavljevicanastrazija theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT ilicaleksandra theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT stojsicsnezana theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT ivanovicvladimir theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT milicevicjelena theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT kovacrobert theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT stefanovicmaja theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT tadicsnezana theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT miljkovictatjana theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT bjelobrkmarija theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT dabovicdragana theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT zivkovsaponjadragoslava theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT petrovicmilovan theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT aleksandarredzek theuseoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT stojsicmilosavljevicanastrazija useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT ilicaleksandra useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT stojsicsnezana useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT ivanovicvladimir useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT milicevicjelena useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT kovacrobert useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT stefanovicmaja useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT tadicsnezana useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT miljkovictatjana useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT bjelobrkmarija useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT dabovicdragana useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT zivkovsaponjadragoslava useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT petrovicmilovan useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia AT aleksandarredzek useoftranspulmonarycontrastechocardiographyafirstexperienceinserbia
_version_	1718440487833042944

The use of transpulmonary contrast echocardiography: A first experience in Serbia

Ejemplares similares